Overview

The Hepatic Hemangioma Nuclear Medicine Study depicts the amount of perfusion (early images) and vascular space (delayed images) within hepatic lesions. Hemangiomas are distinguished by their relatively decreased perfusion and increased vascular volume compared to hepatic parenchyma and most other hepatic lesions.

Indications

• Diagnosis of hepatic hemangiomas.

Study Description

The patient will have some blood drawn that will be used in the Red Cell tagging process. It takes about 45 minutes to tag the patient’s red cells with the radiopharmaceutical. The tagged cells will then be reinjected intravenously and the patient will wait for approximately 1 hour for the radiopharmaceutical to circulate and accumulate. The patient will then be brought into the imaging room for images that will be acquired for 45 minutes.

Examination Time

• Approximately 2 ½ hours (Images acquired for approximately 1 hour).

Patient Preparation

• Ensure the patient is not pregnant or breastfeeding.
• None